Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Wickenstones

Wickenstones is listed as a small business research supplier in the Scientist.com network, with 4 sites in 3 countries.

View Wickenstones on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 4
Countries 3

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Clinical Consulting

  • Patient Advocacy Help patients communicate with their healthcare providers so they get the information they need to make decisions about their health care.

Clinical Trials

  • Post-Marketing (Phase 4) Studies Conduct phase 4 studies for confirming unrecognized safety issues, investigating possible hazards or establishing the expected safety profile of a veterinary medicinal product under market conditions.
  • Prospective Explorative Studies Conduct a prospective exploratory study to assess the safety and efficacy of a test drug during clinical trials.

Commercial Consulting

  • Portfolio Management Manage a portfolio of projects in early-stage drug discovery and provide factors that determine the success of the proposed portfolio.

Creative

  • Infographic Create a quick visual representation of information, data or knowledge.

Drug Development

  • Consulting Services Work with consultants who provide expert advice in various areas of research and technology.

HEOR

  • Clinical Outcome Assessments (Non-Patient Reported) Measure a patient's symptoms, mental state and level of disease condition-related impact on daily life.
  • Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
  • Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
  • Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
  • Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
  • Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
Show all 13 in HEOR 7 more
  • Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
  • HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
  • Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
  • Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
  • Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
  • Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
  • Therapy Switch Insight into the reasoning of patients switching treatments and the outcomes of the switch.
Show all 53 services 41 more

Market Access

  • Communication & Advertisement Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics
  • Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
  • Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
  • Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
  • Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
  • Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
Show all 10 in Market Access 4 more
  • Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
  • Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
  • Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
  • Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.

Medical Communications

  • Medical Publications Make clear and accurate presentations of scientific and technical data.
  • Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
  • Target Product Profile (TPP) A sponsor prepared document which summarizes the drug development program that is described in terms of the labelling concepts. This profile is a communication method used between the FDA and sponsor which can be used...

Medical/Commercial

  • Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.
  • Life Cycle Assessment (LCA) Analyze the lifecycles of the products and services with regard to their environmental impacts.

Old Category HEOR, RWE, Market Access

  • Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
  • Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.

Real World Evidence & Data

  • Claims Data - Medical Includes hospitalization,physician visits,emergency department visits. May or may not include laboratory information including resource utilization, costs or charges, as well as ICD-9 or 10 codes.
  • Clinical Data Registry A study or collection of data regarding the health of patients and the care they receive over different time periods.
  • Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
  • Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
  • Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
  • Patient Reported Outcomes (PRO) Databases Database or collection of data related to health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician or anyone else.
Show all 15 in Real World Evidence & Data 9 more
  • Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
  • Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
  • Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
  • Registries - Disease Database containing, through utilizing observational research methods, standardized data about patients who have the same disease.
  • Registries - Patient Database containing, through utilizing observational research methods, standardized data about patients who have the same condition, disease, or exposure and is used to evaluate an outcome
  • Registries - Product Includes specific information about a product of interest, route of administration, dose, duration of use, start and stop date.
  • Retrospective Exploratory Studies Retrospective exploratory studies
  • RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
  • Secondary Real World Evidence Analyze clinical trial data.

Regulatory Affairs

  • Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)

Other services

  • Observational Research Gain valuable insights into the association between a drug treatment and its outcomes such as long-term effectiveness and safety.

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United Kingdom London, Oxford 2 sites
  • Ireland Carlow 1 site
  • United States Great Neck 1 site

Source: Scientist.com supplier network (site locations)

Get the Wickenstones report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Wickenstones on Scientist.com

For prices, more details, or to contact Wickenstones, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.